Literature DB >> 21548817

Development of an instrument to assess the quality of acupuncture: results from a Delphi process.

Caroline A Smith1, Christopher J Zaslawski, Zhen Zheng, Deidre Cobbin, Suzanne Cochrane, George B Lenon, Bertrand Loyeung, Peter C Meier, Sean Walsh, Charlie Changli Xue, Anthony L Zhang, Xiaoshu Zhu, Alan Bensoussan.   

Abstract

BACKGROUND: Quality acupuncture influences the outcomes of clinical research, and issues associated with effective administration of acupuncture in randomized controlled trials need to be addressed when appraising studies.
OBJECTIVE: The study objective was to achieve consensus on domains and items for inclusion in a rating scale to assess quality acupuncture administered in clinical research. STUDY DESIGN AND
SUBJECTS: An active group of Australian acupuncture researchers initially identified a pool of items assessing quality. The Delphi consensus process was then used to select and reduce the number of items, and an additional expert panel of 42 researchers were invited to participate. Participants initially ranked items along a five-point scale for the first Delphi round, and indicated an agree or disagree response during the second round. For an item to be retained into the second round, an item had to attain greater than 80% agreement that the item described a dimension of quality acupuncture and related study design.
RESULTS: Thirty-two (32) experts agreed to participate in the study. After two rounds of the Delphi process, consensus was reached on 14 domains and 26 items relating to quality acupuncture. Domains, items, and minimum standards related to study design; rationale of the intervention; criteria relating to needling stimulation either manual or electrostimulation; duration and frequency of treatment; and practitioner training.
CONCLUSIONS: Items for inclusion in an instrument to assess quality acupuncture in clinical research were identified. Further development of the instrument including relative weighting of items and reliability testing is under way.

Entities:  

Mesh:

Year:  2011        PMID: 21548817      PMCID: PMC3096500          DOI: 10.1089/acm.2010.0457

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  17 in total

1.  CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.

Authors:  Kenneth F Schulz; Douglas G Altman; David Moher
Journal:  Ann Intern Med       Date:  2010-03-24       Impact factor: 25.391

2.  Assessing the utility of the standards for reporting trials of acupuncture (STRICTA): a survey of authors.

Authors:  Stephanie L Prady; Hugh Macpherson
Journal:  J Altern Complement Med       Date:  2007-11       Impact factor: 2.579

3.  Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.

Authors:  Isabelle Boutron; David Moher; Douglas G Altman; Kenneth F Schulz; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2008-02-19       Impact factor: 25.391

4.  A trial method for assessing the adequacy of acupuncture treatments.

Authors:  A R White; E Ernst
Journal:  Altern Ther Health Med       Date:  1998-11       Impact factor: 1.305

5.  A checklist to evaluate a report of a nonpharmacological trial (CLEAR NPT) was developed using consensus.

Authors:  Isabelle Boutron; David Moher; Peter Tugwell; Bruno Giraudeau; Serge Poiraudeau; Remy Nizard; Philippe Ravaud
Journal:  J Clin Epidemiol       Date:  2005-10-13       Impact factor: 6.437

Review 6.  Acupuncture for peripheral joint osteoarthritis.

Authors:  Eric Manheimer; Ke Cheng; Klaus Linde; Lixing Lao; Junghee Yoo; Susan Wieland; Daniëlle Awm van der Windt; Brian M Berman; Lex M Bouter
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  Defining an adequate dose of acupuncture using a neurophysiological approach--a narrative review of the literature.

Authors:  Adrian White; Mike Cummings; Panos Barlas; Francesco Cardini; Jacqueline Filshie; Nadine E Foster; Thomas Lundeberg; Elisabet Stener-Victorin; Claudia Witt
Journal:  Acupunct Med       Date:  2008-06       Impact factor: 2.267

Review 8.  Acupuncture for tension-type headache.

Authors:  Klaus Linde; Gianni Allais; Benno Brinkhaus; Eric Manheimer; Andrew Vickers; Adrian R White
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21

9.  Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement.

Authors:  Hugh MacPherson; Douglas G Altman; Richard Hammerschlag; Youping Li; Taixiang Wu; Adrian White; David Moher
Journal:  Acupunct Med       Date:  2010-06-08       Impact factor: 2.267

10.  Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews.

Authors:  Beverley J Shea; Jeremy M Grimshaw; George A Wells; Maarten Boers; Neil Andersson; Candyce Hamel; Ashley C Porter; Peter Tugwell; David Moher; Lex M Bouter
Journal:  BMC Med Res Methodol       Date:  2007-02-15       Impact factor: 4.615

View more
  14 in total

1.  Using a Delphi consensus process to develop an acupuncture treatment protocol by consensus for women undergoing Assisted Reproductive Technology (ART) treatment.

Authors:  Caroline A Smith; Suzanne Grant; Jane Lyttleton; Suzanne Cochrane
Journal:  BMC Complement Altern Med       Date:  2012-07-07       Impact factor: 3.659

2.  A new method for quantifying the needling component of acupuncture treatments.

Authors:  Robert T Davis; David L Churchill; Gary J Badger; Julie Dunn; Helene M Langevin
Journal:  Acupunct Med       Date:  2012-03-16       Impact factor: 2.267

3.  Establishing key components of yoga interventions for reducing depression and anxiety, and improving well-being: a Delphi method study.

Authors:  Michael de Manincor; Alan Bensoussan; Caroline Smith; Paul Fahey; Suzanne Bourchier
Journal:  BMC Complement Altern Med       Date:  2015-03-26       Impact factor: 3.659

4.  Beliefs and values in Japanese acupuncture: an ethnography of Japanese trained acupuncture practitioners in Japan.

Authors:  Benjamin Chant; Jeanne Madison; Paul Coop; Gudrun Dieberg
Journal:  Integr Med Res       Date:  2017-07-13

5.  Reliability of the NICMAN Scale: An Instrument to Assess the Quality of Acupuncture Administered in Clinical Trials.

Authors:  Caroline A Smith; Christopher J Zaslawski; Suzanne Cochrane; Xiaoshu Zhu; Zhen Zheng; Bertrand Loyeung; Peter C Meier; Sean Walsh; Charlie Changli Xue; Anthony L Zhang; Paul P Fahey; Alan Bensoussan
Journal:  Evid Based Complement Alternat Med       Date:  2017-06-12       Impact factor: 2.629

Review 6.  Acupuncture and Related Therapies for Treatment of Postoperative Ileus in Colorectal Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yihong Liu; Brian H May; Anthony Lin Zhang; Xinfeng Guo; Chuanjian Lu; Charlie Changli Xue; Haibo Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2018-07-29       Impact factor: 2.629

7.  Faculty survey to assess research literacy and evidence-informed practice interest and support at Pacific College of Oriental Medicine.

Authors:  Belinda J Anderson; Benjamin Kligler; Barry Taylor; Hillel W Cohen; Paul R Marantz
Journal:  J Altern Complement Med       Date:  2014-08-13       Impact factor: 2.579

8.  Electroacupuncture inhibits the interaction between peripheral TRPV1 and P2X3 in rats with different pathological pain.

Authors:  Yingjun Liu; Junying Du; Junfan Fang; Xuaner Xiang; Yingling Xu; Sisi Wang; Haiju Sun; Jianqiao Fang
Journal:  Physiol Res       Date:  2021-06-01       Impact factor: 1.881

9.  TCM Pattern Questionnaire for Lateral Elbow Pain: Development of an Instrument via a Delphi Process.

Authors:  Marcus Gadau; Shi-Ping Zhang; Wing-Fai Yeung; Zhao-Xiang Bian; Ai-Ping Lu
Journal:  Evid Based Complement Alternat Med       Date:  2016-07-20       Impact factor: 2.629

Review 10.  Optimizing acupuncture treatment for dry eye syndrome: a systematic review.

Authors:  Bong Hyun Kim; Min Hee Kim; Se Hyun Kang; Hae Jeong Nam
Journal:  BMC Complement Altern Med       Date:  2018-05-03       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.